| Description |
Anti-mPDCA-1 MicroBeads were developed for the enrichment of mouse plasmacytoid dendritic cells (PDCs) from lymphoid tissues.
The mouse plasmacytoid dendritic cell antigen-1 (mPDCA-1) is specifically expressed on mouse PDCs, a subset of CD11c+ dendritic cells detected at low frequency in all lymphoid tissues, peripheral blood, and some non-lymphoid tissues.1 In mouse spleen, bone marrow, and lymph nodes, mPDCA-1 is exclusively expressed on cells which are CD11clow, CD45R (B220)+, Ly-6Chigh, MHC Class IIlow, CD8alow/-, CD80low/-, CD86-, CD40-, CD11b-, CD90-, CD49b (DX5)-, CD3-, CD19-, i.e. on cells with the phenotype of mouse PDCs. Multi-color fluorescent staining of spleen cells clearly revealed, that all CD11c+ CD45R (B220)+ Ly-6C+ PDCs are mPDCA-1+ and that mPDCA-1 expression is restricted to PDCs. |
| Applications |
Anti-mPDCA-1 MicroBeads allow to enrich mouse PDCs from single-cell suspensions of lymphoid tissues in less than one hour. The isolated PDCs are suitable for studies on their functional properties, e.g. antigen uptake and presentation, crosspriming of cytotoxic T cells, T cell activation or tolerance induction, or T helper cell polarization by PDCs in experimental mouse models of infection and autoimmunity.
Highly pure PDCs were isolated with Anti-mPDCA-1 MicroBeads and have been further analyzed for IDO-dependent tolerance-induction.2 Anti-mPDCA-1 MicroBeads have also been used to isolate PDCs for subsequent analysis of EBV-induced gene 3 (EBI3) expression and regulation in mouse DC subsets.3 |
| |
| Figure 1 |
| Mouse mPDCA-1+ PDCs were enriched from a mouse spleen cell suspension using Anti-mPDCA-1 MicroBeads, two MS Columns, and a MiniMACS™ Separator. The cells are fluorescently stained with Anti-mPDCA-1-FITC and Anti-Ly-6C-PE. Cell debris and dead cells were excluded from the analysis based on scatter signals and PI fluorescence. |
| Spleen cells before separation |
 |
| Spleen cells depleted of mPDCA-1+ PDCs |
 |
| Enriched mPDCA-1+ PDCs |
 |
|
|
